Details for 2012000663

Up to date per 01.04.2026

Actions

Title / Product Name

Verwendung von Zellpermeablen Peptid-Inhibitoren des JNK-Signal-Transduktionspfads zur Behandlung verschiedener Erkrankungen

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012000663

EP Publication Number

2489361

E-Number

662092

Language

PCT Number

Publication Date

22.08.2012 A

16.04.2014 B1

Registration Date

16.04.2014

AT Publication Date

15.05.2014

Application Date

02.06.2009

Registration Number

Priorities

30.05.2008

PCT/EP2008/004341

IPC

A61K 38/01 20060101AFI20120717BHEP

Maximum Duration of Protection

02.06.2029

Owner

Xigen Inflammation Ltd.Arch. Makariou III 195 Neocleous House 3030 LimassolCY

Representative

Mag. Dr. P. N. Torggler, Dipl.Ing. Dr. St. Hofinger, Mag. Dr. M. Gangl, MMag. Dr. C. Maschler INNSBRUCK ( T)

Inventor

Bonny, Christophe37c, chemin du Trabandan 1006 LausanneCH